Skip to content
★ Sign in to follow
Beijing Bohui Innovation Biotechnology Group Co., Ltd. logo

Beijing Bohui Innovation Biotechnology Group Co., Ltd. Stock: price and insider trades · China

博晖创新

CN·Mcap CN¥3.9BHealth Care

Beijing Bohui Innovation Biotechnology Group Co., Ltd.: what insiders have been doing

Beijing Bohui Innovation Biotechnology Group Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Beijing Bohui Innovation Biotechnology Group Co., Ltd. has had no insider filing for more than a year; the last one goes back to 5 January 2022.

Our records for Beijing Bohui Innovation Biotechnology Group Co., Ltd. go back to 2021, with no purchases and 2 sales on the open market in total.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€602,578
2 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 22,838 of 26,911 companies
26.7
score / 100
Value
23
Quality
31
FCF yld-7.5%
Earn yld-2.4%
EV/EBITDA·
ROE-7.6%
Gross mgn40%
Net mgn-11%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥4.78
Analyst consensus
·
Income statement
RevenueCN¥824.6M
Gross profitCN¥326.2M40% margin
EBITDA-CN¥38.5M-5% margin
Net income-CN¥91.9M-10.9% margin
Valuation
P/Book3.1x
Beta0.08
Balance sheet & cash
Market capCN¥3.9B
Total debtCN¥1.1B
Free Cash Flow-CN¥292.1M
Debt / Equity43%
Profitability & ownership
ROE-7.6%
ROA-0.8%
% insiders60.7%
% institutions0.5%
Last declaration on 5 January 2022
Declarations2 total
  • ▼
    高管Executives
    2M CNY16SZSE
    238,000 shares52.8% of flowA股XSHESZSE:173000005206306140
  • ▼
    高管Executives
    2M CNY16SZSE
    268,381 shares47.2% of flowA股XSHESZSE:173000005026253860

2 of 2 declarations

About Beijing Bohui Innovation Biotechnology Group Co., Ltd.

博晖创新 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in developing innovative solutions for the medical field.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations